GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) » Definitions » Inventories, Finished Goods

Zhejiang Conba Pharmaceutical Co (SHSE:600572) Inventories, Finished Goods : ¥0 Mil (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Conba Pharmaceutical Co Inventories, Finished Goods?

Zhejiang Conba Pharmaceutical Co's annual finished goods increased from Dec. 2022 (¥558 Mil) to Dec. 2023 (¥654 Mil) but then declined from Dec. 2023 (¥654 Mil) to Dec. 2024 (¥0 Mil).

Zhejiang Conba Pharmaceutical Co Inventories, Finished Goods Historical Data

The historical data trend for Zhejiang Conba Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Conba Pharmaceutical Co Inventories, Finished Goods Chart

Zhejiang Conba Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 480.21 405.83 557.60 653.62 -

Zhejiang Conba Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 726.67 - - -

Zhejiang Conba Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Zhejiang Conba Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) » Definitions » Inventories, Finished Goods
Comparable Companies
SHSE:600129 SHSE:600211 SZSE:002020 SHSE:600993 SZSE:002675 SHSE:603456 SHSE:600285 SHSE:600267 SHSE:605507 SHSE:600422 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 568 Binkang Road, New and High-Technology Development Zone, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
Website
http://www.conba.com.cn
Zhejiang Conba Pharmaceutical Co Ltd operates as a pharmaceutical company in China. It offers traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. It provides its products under the Conba, Prostate Plus, Zhenshiming, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, and Omeprazole names.
Executives
Hu Ji Qiang Director
Yuan Zhen Xian senior management
Yin Shi Shui Supervisors
Xu Chun Ling senior management
Jin Zu Cheng Directors, senior managers
Ye Jian Feng Supervisors
Ying Chun Xiao Director
Chen Ming Director
Luo Guo Liang Director
Wu Zhong Shi Supervisors
Wang Ru Wei Director
Yang Jun De senior management
Yang Xian Min senior management
Chen Yue Zhong senior management
Li Jian Zhong Supervisors

Zhejiang Conba Pharmaceutical Co Headlines

No Headlines